Page last updated: 2024-09-05

sb 203580 and epirubicin

sb 203580 has been researched along with epirubicin in 2 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (epirubicin)	Trials (epirubicin)	Recent Studies (post-2010) (epirubicin)
3,489	4	1,137	5,453	1,838	1,570

Protein Interaction Comparison

Protein	Taxonomy	sb 203580 (IC50)	epirubicin (IC50)
Genome polyprotein			0.75
Tyrosine-protein kinase Fyn	Homo sapiens (human)		5.181

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, W; Hu, JL; Xiao, L	1
Aligue, R; de Olano, N; Gomes, AR; Koo, CY; Lam, EW; Monteiro, LJ; Pinto, PH	1

Other Studies

2 other study(ies) available for sb 203580 and epirubicin

Article	Year
[Study of the relationship between early growth response gene 1 activity in p38 mitogen-activated protein kinase pathway and epirubicin resistance of human breast carcinoma cells]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2009, Volume: 38, Issue:6 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Early Growth Response Protein 1; Enzyme Inhibitors; Epirubicin; Female; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RNA, Messenger; Signal Transduction	2009
The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment. Molecular cancer research : MCR, 2012, Volume: 10, Issue:9 Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Enzyme Inhibitors; Epirubicin; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Knockdown Techniques; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Serine	2012

Article

Year

[Study of the relationship between early growth response gene 1 activity in p38 mitogen-activated protein kinase pathway and epirubicin resistance of human breast carcinoma cells].

Zhonghua bing li xue za zhi = Chinese journal of pathology, 2009, Volume: 38, Issue:6

Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Early Growth Response Protein 1; Enzyme Inhibitors; Epirubicin; Female; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RNA, Messenger; Signal Transduction

2009

The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.

Molecular cancer research : MCR, 2012, Volume: 10, Issue:9

Topics: Animals; Anthracenes; Antibiotics, Antineoplastic; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Enzyme Inhibitors; Epirubicin; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Knockdown Techniques; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Serine

2012